Biomarkers May Aid in Early Diagnosis of Alzheimer’s
New research suggests that biomarkers in the blood may help diagnose Alzheimer's disease before it progresses, potentially opening the door to better treatments.
While there are currently no treatments that can halt or delay the onset of the disease, the hope is that being able to diagnose Alzheimer's earlier could provide clues about what medication might prevent it from getting worse, the study authors said.
"Most of the research to this point has been done on those who already have Alzheimer's disease," said study author Sid O'Bryant, director of research for the F. Marie Hall Institute for Rural and Community Health at Texas Tech University Health Sciences Center. "We need to be able to identify those at greatest risk."
- CDC Warns of Antibiotic Overuse in Hospitals
- Don't Underestimate Emotional Intelligence
- Two-Midnight Rule Must be Fixed or Replaced, Say Providers
- The Secret to Physician Engagement? It's Not Better Pay
- Care Coordination Tough to Define, Measure
- SCOTUS Review of NC Board Case 'A Very Big Deal' to Providers
- Yale New Haven Health Partners with Tenet Healthcare in CT
- Physicians Take SGR Repeal Message to Washington
- Size Matters in Antibiotic Overuse
- Evidence-Based Practice and Nursing Research: Avoiding Confusion